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Abstract
Objective
To characterize outer retinal structure in Best Vitelliform Macular
Dystrophy (BVMD), using spectral domain optical coherence
tomography (SD-OCT) and adaptive optics scanning light
ophthalmoscopy (AOSLO).
Methods
Four symptomatic members of a family with BVMD with known
BEST1 gene mutation were recruited. Thickness of two outer retinal
layers corresponding to photoreceptor inner and outer segments were
measured using SD-OCT. Photoreceptor mosaic AOSLO images within
and around visible lesions were obtained, and cone density was
assessed in two subjects.
Results
Each subject was at a different stage of BVMD, with
photoreceptor disruption evident by AOSLO at all stages. When
comparing SD-OCT and AOSLO images from the same location, AOSLO
images allowed for direct assessment of photoreceptor structure. A
variable degree of retained photoreceptors was seen within all lesions.
The photoreceptor mosaic immediately adjacent to visible lesions
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appeared contiguous and was of normal density. Fine hyperreflective
structures were visualized by AOSLO, and their anatomical orientation
and size are consistent with Henle fibers.
Conclusions
AOSLO findings indicate substantial photoreceptor structure
persists within active lesions, accounting for good visual acuity in
these patients. Despite previous reports of diffuse photoreceptor outer
segment abnormalities in BVMD, our data reveal normal photoreceptor
structure in areas adjacent to clinical lesions.
Clinical Relevance
This study demonstrates the utility of AOSLO for understanding
the spectrum of cellular changes that occur in inherited degenerations
such as BVMD. Photoreceptors are often significantly affected at
various stages of inherited degenerations, and these changes may not
be readily apparent with current clinical imaging instrumentation.
Best Vitelliform Macular Dystrophy (BVMD), also known as
Vitelliform Macular Dystrophy type 2 or Best’s Disease (OMIM #
607854; BEST1)is an autosomal dominant form of macular
degeneration of variable penetrance characterized by varying
accumulation of yellowish vitelliform material in the macula.1,2 Affected
individuals also show a reduction in the electrooculogram (EOG) light
peak but a normal full-field electroretinogram (ERG).1,3 Mutations in
the BEST1 gene on chromosome 11q13 encoding bestrophin-1 cause
BVMD.4–6 Bestrophin-1 is an integral membrane protein that has been
localized to the basolateral membrane of the retinal pigment
epithelium (RPE)7 and is thought to be a Ca+2 sensitive Cl− channel
protein or influences the regulation of Ca+2 channels.8
The clinical appearance of BVMD varies by the stage of the
disease.2 Initially, retinal fundi may appear normal (previtelliform).
Characteristically, there is development of macular fluid- and debrisfilled retinal detachments forming a yellow yolk-like or vitelliform
lesion or lesions. With time, the vitelliform material may become more
heterogenous with various layers (pseudohypopyon) and may appear
to dissolve, leaving isolated clumps of material at the edges of the
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lesion (vitelliruptive). Eventually localized atrophy and fibrosis
develops in the location of the vitelliform lesion.2 Despite presence of
vitelliform lesion(s), vision is usually good in earlier stages of the
disease, visual acuity of 20/40 or better vision being reported in 76%
of individuals less than 40 years of age.9 It has been shown that
normal acuity can be maintained in individuals having substantial
photoreceptor degeneration.10,11 Thus, the good visual acuity in
patients with BVMD does not necessarily inform about the degree of
photoreceptor degeneration.
Histopathologic findings from BVMD donor eyes are limited but
demonstrate abnormal accumulation of lipofuscin granules in the
RPE12–15 and photoreceptor degeneration over areas of intact RPE.16,17
Recently a knock-in mouse model of BVMD showed increased
accumulation of lipofuscin in the RPE and deposition of subretinal
debris composed of unphagocytosed photoreceptor outer segments
and lipofuscin granules.18 It is hypothesized that impairment (rather
than loss) of RPE to fully degrade phagocytosed outer segments leads
to photoreceptor degeneration in BVMD, either alteration of the ionic
milieu of the subretinal space due to bestrophin mistargeting or loss of
cell-to-cell contact.13,16
Optical coherence tomography (OCT) imaging techniques allow
for non-invasive assessment of retinal structure, and numerous studies
have utilized this imaging approach to assess outer retinal structure in
BVMD.19–23 OCT imaging has shown that the characteristic vitelliform
lesions of BVMD are the result of accumulation of material in the
subretinal space above the RPE and below the outer segments of the
photoreceptors.20,21,24,25 Also, despite bestrophin–1 being localized to
the RPE, OCT has shown significant changes to outer retinal structure
are evident at various stages of the disease, and it has been suggested
that thickening of the reflective layer corresponding to the
photoreceptors may be one of the earliest anatomical changes visible
by OCT with BVMD.20,21,26 However, examples exist where the
resolution of existing OCT technology is not sensitive enough to detect
pronounced photoreceptor disruption.27–29 Thus, despite the OCT
findings in BVMD, the nature of photoreceptor structure in BVMD
remains unclear.
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Adaptive optics (AO) imaging systems enable cellular-resolution
imaging of the human retina, allowing for direct visualization of cone
and rod photoreceptor mosaic.30,31 To better understand photoreceptor
structure across the spectrum of BVMD, we used spectral-domain OCT
(SD-OCT) and adaptive optics scanning light ophthalmoscopy (AOSLO)
to assess retinal structure in four members of the same family who are
at various stages of BVMD and have a known BEST1 mutation.

Methods
Four members of a family with a previously identified mutation,
p.Arg218Cys (c.652C->T) (University of California Ophthalmic
Molecular Diagnostic Lab, La Jolla, CA), in the BEST1 gene reported to
be causative mutation in BVMD32 and with clinical findings consistent
with BVMD participated (Table 1, eFigure 1). The p.Arg218Cys
mutation is predicted to affect the charge of the bestrophin protein,
altering its function. Visual acuity was assessed, and a comprehensive
eye exam including fundus photography was performed for all four
subjects. Each patient was dilated using one drop of phenylephrine
(2.5%). Mircoperimerty was performed. Then accommodation was
suspended using one drop of tropicamide (1%) for subsequent highresolution imaging. Axial length was measured using an IOL Master
(Carl Zeiss Meditec, Dublin, CA). This prospective study was conducted
in accordance with the tenets of the Declaration of Helsinki and with
institutional review board approval.

Mutation
Age,
in Best1
Subject y Gender
gene

Type of
Lesion*

Eye
Visual
Axial
imaged
Acuity** Length (OD,
with
(OD, OS) OS, mm)
AOSLO

IV-3

16

M

Arg218Cys
(c.652C>T)

Early
vitelliform

20/20,
20/20

22.57/22.14

OS

IV-2

18

F

Arg218Cys
(c.652C>T)

Vitelliform
with early
vitelliruptive

20/20,
20/20

22.72/22.62

OS

III-5

50

F

Arg218Cys
(c.652C>T)

Late
vitelliruptive

20/30,
20/100

22.11/21.98

OD

III-4

59

F

Arg218Cys
(c.652C>T)

Atrophic

20/200,
20/50

23.14/23.69

OS
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Table 1 Patient Demographics
*Same

lesion type in both eyes,

**Snellen

y-years, OD –right, OS –left, M-male, F- female, mm- millimeters

Macular microperimetry was performed using the Spectral
OCT/SLO MP system (OPKO instrumentation) after a brief training to
allow for familiarization of the test. A Polar 3 standardized grid
composed of 28 points arranged in 3 concentric circles (2.3°, 6.6°, and
11° in diameter from fovea, 4 points in innermost circle, 12 in middle
and outer circles) was performed using a Goldman III stimulus, a
200ms duration and a test strategy 4-2. Results were compared to
previously published normative data33.
Volumetric images of the macula were obtained using Cirrus
HD-OCT (Carl Zeiss Meditec, Dublin, CA). Volumes were nominally 6
mm × 6 mm and consisted of 128 B-scans (512 A-scans/B-scan).
Retinal thickness was assessed using the built-in macular analysis
software (software version 5.0), which is automatically generated by
calculating the difference between the inner limiting membrane (ILM)
and RPE boundaries. The software’s “fovea finder” algorithm was used
to determine the location of the fovea on the line scanning
ophthalmoscope (LSO) image. Additional high-density line scans (1000
A-scans/B-scan, 100 repeated B scans) were acquired through the
foveal center in the study eye of each participant using the Bioptigen
SD-OCT (Bioptigen, Inc., Research Triangle Park, NC). Line scans were
registered and averaged to reduce speckle noise in the image using
previously described techniques,34 and were acquired in both the
horizontal and vertical direction. All scans shown in the figures are
from the Bioptigen device. Numerous naming conventions exist in the
literature for the outer hyperreflective layers in SD-OCT scans, so it is
important to define the one used here. Shown in Figure 1 is a
horizontal line scan from a normal control, and a corresponding
longitudinal reflectivity profile (LRP), showing the identity of the bands
analyzed.35,36 The innermost band corresponds to the external limiting
membrane (ELM), the second band corresponds to the inner segment
ellipsoid (ISe),37 the third band corresponds to the outer segment/RPE
interface (RPE1), and the fourth band corresponds to the RPE (RPE2).
The peak-to-peak distance between the ELM and ISe is taken as the
length of the inner segments (IS), while the peak-to-peak distance
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between the ISe and RPE1 is taken as the length of the outer
segments (OS). While these may not correspond precisely to the
absolute IS or OS length, we utilized these same definitions in an
extensive previously published normative dataset.36 We examined the
IS and OS length across the horizontal line scan from each subject,
sampling the scan at 0.2mm intervals. We excluded the central BVMDrelated lesion from further analysis, similar to a previous report.21
Images of the photoreceptor mosaic were acquired using a previously
described AOSLO.30,38 Images were obtained using an Inphenix 775nm
superluminescent diode 12nm FWHM bandwidth with either a,1.0 or
1.75 degree square field of view. The fovea and surrounding areas
affected by pathology were imaged in each patient. Parafoveal images
(~0.65 degrees from fixation) were acquired by instructing the patient
to fixate on the corners or edges of the raster, while more eccentric
images were acquired using an internal fixation target. Intraframe
distortions within the AOSLO retinal images were corrected as
previously described.30,39 Registration of frames within a given image
sequence was performed using a “strip” registration method, in which
the images were registered by dividing the image of interest into
strips, aligning each strip to the location in the reference frame that
maximizes the normalized cross correlation between them.39 Once all
the frames were registered, the 50 frames with the highest normalized
cross correlation to the reference frame were averaged, in order to
generate a final image with an increased signal to noise ratio (SNR).

Figure 1

Assignment of outer retinal bands on SD-OCT. Shown is a horizontal line

scan through the fovea of a normal subject. The graph on the right is a longitudinal
reflectivity profile (LRP) acquired at the location of the vertical black arrow above the
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SD-OCT scan. ELM=external limiting membrane, ISe=inner segment ellipsoid,
RPE1=outer segment/RPE interface, RPE2=RPE.

These registered and averaged AOSLO images were then
montaged using Adobe Photoshop (Adobe Systems, Inc., CA). The
montage was aligned to the color fundus images and the LSO image
from the Cirrus HD-CT, which was exported with the location of the
foveal pit marked. Scaling of the images was done based on the
expected scale of each image and alignment was done manually
utilizing blood vessel patterns. Cone density was assessed using 55μm
× 55μm sampling areas adjacent to the visible lesion in two subjects
and near the fovea within the active lesion in all four subjects using a
previously described semi-automated algorithm.40 The distance
between the sampled area and the foveal pit was measured, enabling
comparison of density values to previously published normative
values.

Results
Four affected subjects from a family with BVMD with known
p.Arg218Cys mutation in BEST1 gene participated. (eFigure 1) All
family members were found to be at different stages of the disease,
summarized in Table 1. The SD-OCT and AOSLO imaging findings were
unique to each stage (Figures 2–5).. Macular microperimetry
performed within a 6 degree radius of the fovea revealed areas of
subnormal individual point sensitivities in regions corresponding to
clinical retinal lesions (lower left, Figures 2–5) in all but subject IV-3
with early vitelliform findings. In patient IV-2, decreased point
sensitivities were seen both in regions surrounding the vitelliform
lesion and overlying the lesion itself.
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Figure 2

Imaging of IV-3, left eye – Early vitelliform findings. Fundus exam

revealed a focal area of granularity just temporal to the fovea (upper left). SD-OCT
horizonal and vertical scans show normal retinal lamination but focal increased hyperreflectivity in the area of granularity seen clinically (upper right). Macular
microperimetry showed normal point sensitivities in the central 12 degrees (overlay,
left lower) Adaptive optics imaging of this location (montage registered lower left, area
imaged indicated by arrows on SD-OCT upper right) shows focal photoreceptor mosaic
disruption around the area of hyper-reflectivity on OCT with photoreceptor mosaic
surrounding this area appearing normal (lower right).
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Figure 5 Imaging of III-4, left eye - Atrophy and Fibrosis. Fundus exam shows
central hypopigmentation with focal pigment mottling and trace epiretinal membrane
(ERM) (upper left). SD-OCT horizontal and vertical scans show a lamellar hole, trace
ERM and loss of the hyperreflective ISe band (upper right). Macular microperimetry
revealed subnormal point sensitivities in areas central and temporal to fovea when
fibrosis and atrophy are present clinically (overlay, left lower). Adaptive optics imaging
of central fovea (montage registered lower left, area imaged indicated by arrows on
SD-OCT upper right) reveal patchy areas of retained photoreceptors between areas of
significant photoreceptor loss (lower right).

Measurement of IS and OS retinal thickness was performed
using the SD-OCT horizontal line scan in all four subjects. Shown in
Figure 6 is the IS and OS thickness profile in areas immediately
adjacent to clinical visible lesions for all four subjects compared to
data from a previously published normative group.41 Thickness values
were not calculated over the visible lesion. All 4 subjects were found to
have IS and OS thickness values within 2 standard deviations of
normative data.
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Figure 6

Assessment of photoreceptor layer thickness in BVMD. Top, plot of inner

segments (IS) length as a function of retinal location along the horizontal meridian.
Bottom, outer segment (OS) length as a function of retinal location along the
horizontal meridian. Black line – normative data from 93 people, average age 25.7
years with standard deviation (stdev) of 8.2 years. Shaded grey area is + 2 stdev.
Open squares – subject IV-2, Open circles – subject IV-3, Filled squares – subject III-
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5, Filled circles – subject III-4. Thickness values were not calculated over visible
lesion(s).

We sought to further assess photoreceptor structure in the
retinal area adjacent to the BVMD lesions. In two patients having
lesions with a clear boundary, we were able to obtain AOSLO
montages that were large enough to encompass the entire lesion
(Figure 2, eFigure 2). We assessed cone density just nasal to the
lesion boundary in both IV-3 and IV-2, and determined that the areas
sampled were 1 degree from the foveal center. The cone mosaic
appeared contiguous and cone density was 55,900 cones/mm2 in IV-3
and 43, 700 cones/mm2 in IV-2. Both values are within the normal
range for this retinal eccentricity.41
In the SD-OCT scans of one of the subjects (IV-2) we noticed
significant hyperreflective material in the outer nuclear layer (ONL).
This has been previously reported in BVMD,42 and is attributed to the
physical deformation of the Henle fiber layer by the underlying
vitelliform lesion. Inspection of the SD-OCT volume revealed the
strongest signal in the inferior retina, just nasal to the fovea. AOSLO
images from this same location focused in the inner retina revealed
thin hyperreflective structures running perpendicular to the nerve fiber
layer (Figure 7). The anatomical location and orientation is consistent
with that of Henle fibers, and the diameter of these structures
(average = 2.76 ± 0.32 μm) is consistent with previous histology
reports.43
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Figure 7

Visualization of Henle fiber layer in BVMD. Presence of the vitelliform

lesion has altered the angle of retina structure, allowing for visualization of Henle fiber
layer on SD-OCT (arrows, top). AOSLO imaging at this same location focused at the
level of the inner retina revealed thin hyperreflective structures running perpendicular
to nerve fiber bundles, consistent with known anatomy of Henle fibers (lower).

Comment
In our study we used SD-OCT and AOSLO to assess outer retinal
structure in four members of a single family harboring a previously
reported BEST1 mutation (p.Arg218Cys). The phenotypes ranged from
early vitelliform changes to a central atrophic area. Disruption of the
cone mosaic was evident in the AOSLO images at all stages of BVMD
presented here, including the patient with the earliest stage of
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vitelliform clinical findings (Figure 2), suggesting this is an early
finding in patients with BVMD. The degree of this photoreceptor
disruption varied by stage of disease, and was often patchy with areas
of significant photoreceptor disruption surrounded by areas of a
contiguous photoreceptor mosaic, even in the patient with advanced
atrophy and fibrosis. (Figure 5) It is important to note that disruption
of visualization of cone structure on AOSLO does not necessarily mean
the cone cell has been lost. When comparing SD-OCT and AOSLO
images from the same location, the AOSLO images allowed for better
understanding of the degree of retained photoreceptor structure at
that location. This is illustrated in the patient with late vitelliruptive
changes (Figure 4). SD-OCT of this individual shows significant
disruption of the hyperreflective ISe band in the areas of subretinal
nodules, but the AOSLO images reveal islands of contiguous cone
mosaic adjacent to areas of significant disruption.
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Figure 4

Imaging of III-5, right eye – Vitelliruptive. Fundus exam reveals an ovoid

area of hypopigmentation containing several fibrotic nodules (upper left). SD-OCT
horizontal and vertical scans show outer retinal atrophy and several focal deposits of
debris in the subretinal space, some separated by trace subretinal fluid. Patchy
disruption of the hyperreflective ISe band is evident in some areas (upper right).
Macular microperimetry revealed subnormal point sensitivities in all areas of central 6
degrees (overlay, left lower). Adaptive optics imaging of central fovea (montage
registered lower left, area imaged indicated by arrows on SD-OCT upper right) reveals
significant photoreceptor mosaic disruption overlying these nodules, but relative
preservation of the photoreceptor mosaic surrounding these lesions (lower right).

Previous studies have suggested that loss of photoreceptors in
BVMD could be widespread and not necessarily confined to the
clinically apparent lesions, and support for this comes from the fact
that bestrophin, the RPE membrane protein encoded by the BEST1
gene, is found throughout the retina in individuals unaffected by
BVMD.17 Kay et al. recently showed increased photoreceptor thickness
on SD-OCT in patients with BVMD when compared to normal controls
within the macular region.21 Based on their findings, they conclude
that the primary anatomical impact is at the photoreceptor level.
Certainly, our finding that the photoreceptor mosaic is disrupted in the
earliest stage of clinical vitelliform findings would be consistent with
this proposed etiology, but our finding of normal IS and OS thickness
and normal cone density in retinal areas adjacent to visible lesions
argues against a diffuse structural deficit in BVMD. One possible
explanation is that the previous study did not correct the lateral scale
of their SD-OCT scans for individual differences in axial length,
meaning that different extents of retina contributed to the analysis in
each retina. Moreover, since the previous analysis averaged the
thickness measurements across the scan, it is unclear if the retina was
indeed uniformly affected or if a small retinal area was severely
abnormal.21 Nevertheless, while our findings do not support diffuse
disruption of the cone mosaic outside the lesion, it is possible that
these cells may not be functioning normally.
Interestingly, macular microperimetry revealed areas of
subnormal point sensitivities in areas surrounding the vitelliform lesion
in subject IV-2. Both SD-OCT and AOSLO showed normal outer retinal
anatomy within these regions. These reduced point sensitivities may
be result of eye movements reducing the specificity of registration to
the fundus. However, it may also be possible that functional loss of
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vision precedes anatomical outer retinal structural loss. High resolution
microperimetric assessment using adaptive optics technology has been
described.44,45 To better understand and correlate functional vision to
photoreceptor mosaic structure pathology, future studies would benefit
from AOSLO based microperimetry allowing for functional assessment
at resolutions on par to those used to assess retinal structure.
It is becoming appreciated that outer retinal pathology can
affect the appearance of the overlying retina on SD-OCT. For example,
presence of a vitelliform lesion, large drusen, or pigment epithelial
detachment alters the orientation of the fibers of Henle as they
traverse the lesion, altering their reflectivity on SD-OCT.46,47 We also
observed this effect in one of our subjects (IV-2), however we also
observed the presence of fine hyperreflective structures running
perpendicular to the nerve fiber bundles in the AOSLO images at the
same retinal location (Figure 7). Their anatomical location, orientation,
and size are consistent with that of Henle fibers. As seen with SD-OCT,
this demonstrates that when imaged with AOSLO, outer retinal
disruptions can alter the appearance of the inner retina, and this
should be taken into consideration when analyzing such images.
A potential limitation of the current study is that all four
subjects have the same genetic mutation in the BEST1 gene. While our
data reveal a spectrum of clinical and subclinical findings associated
with this particular mutation, it is not possible to extend our findings
on the integrity of the cone mosaic to other mutations. Future
investigations should include high-resolution imaging of other
individuals with different mutations in BEST1 gene to investigate
possible genotype-dependent differences in photoreceptor structure.
In summary, we provide evidence from cellular imaging with
AOSLO that photoreceptor structure can be retained within active
BVMD lesions, even in apparently atrophic lesions. This photoreceptor
structure is capable of supporting rather good visual acuity, as visual
acuity in the eyes imaged here ranged from 20/20 to 20/50. In
addition, our SD-OCT and AOSLO data show normal photoreceptor
structure in retinal areas outside the clinically visible lesion, in contrast
to previous reports21, but consistent with previous findings with
AOSLO.48 This may represent a specific feature of the mutation studied
here, or be due to different imaging and measurement procedures.
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Regardless, our study highlights the utility of AOSLO imaging in
directly delineating the degree of retained photoreceptor structure in
diseases like BVMD. In particular, combining information from SD-OCT
with that from AOSLO gives a complementary view of outer retinal
structure and provides a more sensitive approach for measuring
photoreceptor structure than either alone.

Figure 3

Imaging of IV-2, left eye – Vitelliform lesion with early vitelliruptive

changes. Fundus exam reveals single heterogeneous vitellform lesion centered just
temporal to fovea (upper left). SD-OCT horizonal and vertical scans show the
vitelliform lesion contains fluid and debris within the subretinal space. There is patchy
disruption of the hyperreflective ISe band over the lesion (upper right). Macular
microperimetry revealed subnormal point sensitivities in areas overlying the vitelliform
lesion and immediately surrounding it. (overlay, left lower). Adaptive optics imaging of
the vitelliform lesion and area immediately surrounding this (montage registered lower
left, area imaged indicated by arrows on SD-OCT upper right) reveals disrupted
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photoreceptor mosaic over the lesion with normal mosaic seen immediately adjacent
to the lesion.

Supplementary Material
Supp Figure 1

eFigure 1:

Pedigree of family with Best Vitelliform Macular Dystrophy caused by

Arg218Cys (c.652C>T) mutation in BEST1 gene. Individuals marked with “*” were
imaged in this study. (will be moved from here…)
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